• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Harbour BioMed announces partnership with Kelun-Biotech biospectrumasia
    August 22, 2018
    The companies will also collaborate in developing combination therapies of A167 with other agents for commercialization in their respective territories.
  • Harbour BioMed, Kelun-Biotech Enter Agreement fiercebiotech
    August 22, 2018
    Harbour BioMed has entered into an exclusive strategic partnership with Kelun-Biotech to develop and commercialize A167, an anti-PD-L1 antibody in Phase 2 clinical development, worldwide outside of the Greater China region.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service